引领中国母乳化进程 打破行业卡脖子局面 来源：黑龙江日报 全媒体记者 姚建平 □文/摄 贺菲 在日前召开的第六届全国杰出专业技术人才表彰大会上，黑龙江飞鹤乳业有限公司董事长、高级工程师 冷友斌荣获"全国杰出专业技术人才"荣誉称号。 作为飞鹤乳业的当家人，冷友斌带领企业在婴儿奶粉行业创造了多项第一。完成国内第1个婴幼儿配方 奶粉临床喂养试验，推出国内首款母乳化高端婴幼儿奶粉，提出"更适合中国宝宝体质"的理念引领国产 奶粉差异化发展；历时10年，铸就中国婴幼儿奶粉行业第1个全产业集群，在国内婴幼儿奶粉行业第1家 推出可追溯系统，并升级成为业内首家实现双屏互动可视化全产业链企业；成为第1家在美国纽交所主 板上市的中国婴幼儿奶粉企业、第1家制定新鲜产品标准的中国婴幼儿奶粉企业、第1家荣获国家质量监 督检验检疫总局颁布的"生态原产地产品保护认证"的奶粉企业。 冷友斌先后主持参与了国家863、国家"十二五"国家科技支撑计划、国家星火等项目，带领研发团队对 中国母乳进行系统化研究，建立中国母乳数据库，在全球首发三大母乳研究成果，研究描述了中国母乳 三大类脂肪酸关键比例，成功开发出国内首款母乳化婴幼儿奶粉"星飞帆"，完成了中 ...

2025年的中国奶粉市场，在多重变量交织中绘就了一幅"冰与火"的行业图景：一边是新生儿数量持续承 压、存量竞争日益激烈，另一边却是多家主流乳企业绩逆势回升，高端与超高端奶粉赛道增长强劲。 随着国家层面生育补贴政策首次以现金形式落地，以及消费升级趋势在低线市场持续渗透，奶粉行业在 深度调整后迎来结构性复苏。系统复盘2025年中国奶粉行业的变革与突围可以看到，奶粉销售回暖并非 偶然，而是乳企多年深耕产品、渠道与品牌的结果。 多家乳企业绩逆势回暖 高端赛道成增长引擎 2025年上半年，国内奶粉市场呈现出显著的业绩分化与整体回暖态势。以健合集团、澳优乳业、伊利等 为代表的多家乳企，在婴幼儿配方奶粉板块实现营收与利润双增，扭转了此前行业整体增速放缓甚至下 滑的局面。 伊利奶粉及奶制品业务收入同比增长14.26%，婴幼儿奶粉零售额实现双位数增长，市场份额达到 18.1%，首次跃居中国市场第一；蒙牛奶粉业务也实现2.46%的增长。 健合集团半年报显示，公司上半年营收同比增长5.2%至70.2亿元，其中婴幼儿营养与护理业务（BNC） 营收25.0亿元，同比增长2.9%。尽管BNC增速在集团三大业务中居末，但标志着该业务成功止 ...

2025年的中国奶粉市场，在多重变量交织中绘就了一幅"冰与火"的行业图景：一边是新生儿数量持续承压、存量 竞争日益激烈，另一边却是多家主流乳企业绩逆势回升，高端与超高端奶粉赛道增长强劲。 随着国家层面生育补贴政策首次以现金形式落地，以及消费升级趋势在低线市场持续渗透，奶粉行业在深度调整 后迎来结构性复苏。系统复盘2025年中国奶粉行业的变革与突围可以看到，奶粉销售回暖并非偶然，而是乳企多 年深耕产品、渠道与品牌的结果。 外资品牌方面，达能中国专业特殊营养业务销售同比增长12.9%，a2牛奶、菲仕兰等也录得正向增长。然而，市 场并非全面繁荣——飞鹤、贝因美等部分头部企业上半年业绩仍面临压力，显示出行业在复苏过程中结构性分化 的特征。 高端赛道成增长引擎 2025年上半年，国内奶粉市场呈现出显著的业绩分化与整体回暖态势。以健合集团、澳优乳业、伊利等为代表的 多家乳企，在婴幼儿配方奶粉板块实现营收与利润双增，扭转了此前行业整体增速放缓甚至下滑的局面。 伊利奶粉及奶制品业务收入同比增长14.26%，婴幼儿奶粉零售额实现双位数增长，市场份额达到18.1%，首次跃 居中国市场第一；蒙牛奶粉业务也实现2.46%的增长。 到 ...

Core Viewpoint - The article highlights the revitalization of Northeast China through the stories depicted in the microfilm series "Northeast Really Works," showcasing the resilience and transformation of the region and its people [1][27]. Group 1: Resilience and Transformation - The microfilm "Searching for Liu Bo Kui" illustrates the journey of discovering the essence of those who stayed in Qiqihar, emphasizing their contributions as workers and their evolution into modern roles [3][4]. - The character "Liu Bo Kui" symbolizes the collective spirit of the people who have remained in Qiqihar, showcasing their dedication and adaptability in various professions [3][4]. - The growth of companies like Feihe reflects the Northeast spirit, demonstrating a commitment to local development and innovation despite challenges [4][6]. Group 2: Economic and Social Impact - Feihe's initiatives have led to significant advancements in the infant formula industry, including the establishment of a national research team focused on maternal health and infant nutrition [6][10]. - The company has created 170,000 jobs and increased the income of over 160,000 farmers, contributing to local economic growth and community welfare [10][11]. - Feihe's commitment to social responsibility is evident through its various philanthropic efforts, including healthcare initiatives that enhance local medical capabilities [11][13]. Group 3: Cultural Significance - The microfilm "The Secret of Barbecue" explores the cultural identity of Qiqihar through its culinary traditions, emphasizing the genuine and heartfelt approach of local businesses [14][15]. - The article draws parallels between the local food culture and Feihe's dedication to quality, portraying both as representations of the Northeast spirit [17][24]. - Feihe's recognition, such as the China Quality Award, underscores its commitment to excellence and its role as a leading brand in the infant formula market [19][20][22]. Group 4: Future Prospects - The stories in "Northeast Really Works" encapsulate the ongoing journey of revitalization, highlighting the importance of both the older generation's experience and the younger generation's return to their roots [27]. - The collaboration between traditional values and modern innovation is seen as a pathway for sustainable development in Northeast China [9][24]. - Feihe's focus on creating products tailored to the needs of Chinese infants positions it as a key player in the global dairy industry, contributing to the narrative of Northeast revitalization [24][27].

Group 1 - The series of microfilms titled "Northeast Really Works" highlights the resilience and transformation of Northeast China, showcasing the stories of local people and their contributions to the region's revival [1][3][32] - The character "Liu Bokui" symbolizes the collective spirit of those who chose to stay in Qiqihar, representing various professions and their dedication to the land [3][5] - The film emphasizes the importance of local enterprises like Feihe, which embodies the Northeast spirit and has evolved through challenges, contributing to the region's economic growth [5][7][30] Group 2 - Feihe has established itself as a leading domestic brand in infant formula, focusing on quality and innovation, and has rejected foreign acquisition offers to maintain its independence [5][27] - The company has initiated significant research projects, collaborating with top universities to enhance the innovation capabilities of China's infant formula industry [7][11] - Feihe's commitment to community development is evident through its initiatives that create jobs and improve the livelihoods of local farmers, contributing to rural revitalization [11][13][15] Group 3 - The company has implemented a comprehensive approach to quality control, ensuring that every product meets high standards, which is crucial for the health of the next generation [27][29] - Feihe's dedication to social responsibility is reflected in its various philanthropic efforts, including healthcare initiatives that improve local medical services [16][18] - The brand's success is intertwined with the cultural identity of Northeast China, as it represents the region's values of sincerity and dedication in its business practices [19][23][30]

Core Viewpoint - China Feihe Dairy has been awarded the nomination for the 5th China Quality Award, becoming the only infant formula company to receive this honor, which signifies a significant recognition of its quality management practices and a milestone for the Chinese dairy industry [1][2]. Group 1: Award Significance - The China Quality Award is the highest honor in quality management, established by the central government and organized by the State Administration for Market Regulation, aimed at recognizing significant innovations in quality management [2]. - Feihe's nomination alongside major companies in aerospace, new energy, and heavy industry highlights its quality management system's alignment with national standards [2]. Group 2: Quality Management Practices - Feihe has maintained a record of zero accidents in safety production for 63 years, emphasizing its commitment to quality as the lifeline of the company [4]. - The company implements a "dual-chain integration" model of intelligent manufacturing quality management, integrating the entire industry chain with technological innovation [7][10]. Group 3: Research and Development - Feihe leads national research initiatives on breast milk, establishing the largest maternal and infant health cohort in China and developing a comprehensive database for HMOs [8]. - The company has innovatively applied research findings to its products, achieving a DHA:ARA ratio of 1:1.7 and high levels of active N-glycans in its formulations [8][12]. Group 4: Technological Innovations - Feihe has established a rigorous quality assurance system, including a cleanroom standard equivalent to pharmaceutical-grade facilities and innovative detection methods that significantly enhance efficiency [10][11]. - The company has adopted AI technologies for real-time monitoring of the entire production process, improving supply chain efficiency by 40% [11]. Group 5: Market Position and Recognition - Feihe has maintained the top position in the Chinese infant formula market for six consecutive years and has been the global leader in sales for four years [11][12]. - The brand's recognition rate reached 99% in Q2 2025, solidifying its position in consumer awareness [11]. Group 6: Future Outlook - Feihe aims to continue its commitment to quality and technological innovation, enhancing its quality management system to lead the industry towards high-quality development [14].

Core Viewpoint - China Feihe Dairy has been awarded the nomination for the 5th China Quality Award, becoming the only infant formula company to receive this honor, which signifies a significant advancement in the quality management level of China's dairy industry [1][4][6] Group 1: Quality Management Achievements - The China Quality Award is the highest honor in quality management, established by the central government, aimed at recognizing significant innovations in quality management models and methods [4] - Feihe's innovative quality management model has set a benchmark for the dairy industry and is seen as a vital reference for promoting high-quality development in China's manufacturing sector [1][4][6] - Feihe has maintained a record of zero accidents in safety production for 63 years, emphasizing its commitment to quality as the lifeline of the enterprise [5][7] Group 2: Technological Innovations - Feihe has developed a comprehensive industrial cluster that integrates grass planting, feed processing, large-scale breeding, production, and logistics, ensuring quality control from source to end [5][6] - The company has established a rigorous quality assurance system, including a 10,000-level cleanroom standard and innovative detection methods that significantly enhance efficiency and accuracy [7] - Feihe's AI-based production management system allows for real-time monitoring of the entire milk powder production process, improving supply chain efficiency by 40% [7] Group 3: Market Position and Recognition - Feihe has ranked first in the Chinese infant formula market for six consecutive years and has been the global leader in sales for four years [8][10] - The brand has achieved a recognition rate of 99% among consumers, solidifying its position in the market [8] - Feihe has received numerous awards, including the World Food Quality Award and the National Technology Innovation Demonstration Enterprise title, reflecting its commitment to quality and innovation [10][11] Group 4: Future Directions - The company aims to continue its focus on quality and technological innovation, enhancing its quality management system to lead the high-quality development of the dairy industry [13]

Core Viewpoint - China Feihe Dairy has been awarded the nomination for the 5th China Quality Award, becoming the only infant formula company to receive this honor, which signifies a significant advancement in the quality management level of China's dairy industry [1][4][6]. Group 1: Award Significance - The China Quality Award is the highest honor in quality management, established by the central government and organized by the State Administration for Market Regulation, aimed at recognizing significant innovations in quality management [4]. - Feihe's nomination is a testament to its long-standing commitment to high-quality development and serves as a benchmark for the dairy industry [1][4]. Group 2: Quality Management Practices - Feihe has maintained a record of zero accidents in safety production for 63 years, emphasizing its core principle that quality should not be compromised [6][12]. - The company has developed a comprehensive quality management system, including 1,322 quality management regulations covering all processes from farming to production [12]. Group 3: Innovation and Research - Feihe has established an integrated industrial chain model that combines agriculture, animal husbandry, and manufacturing, ensuring quality control from source to end product [7][10]. - The company leads national research on breast milk, creating the largest maternal and infant health database in China, which supports the development of infant formula tailored to Chinese babies [10][15]. Group 4: Market Position and Recognition - Feihe has been the top seller in the Chinese infant formula market for six consecutive years and ranks first globally in sales [13][15]. - The brand has achieved a recognition rate of 99% among consumers, solidifying its position as a market leader [13]. Group 5: Future Directions - Feihe aims to continue its commitment to quality and innovation, enhancing its quality management system to lead the high-quality development of the dairy industry [16].

Group 1 - The Chinese dairy market is in a recovery phase as of mid-2025, with major companies like Yili, Mengniu, and China Feihe leading in market capitalization [1] - Among the top five companies, four have revenues exceeding 10 billion yuan, with Yili at 61.3 billion yuan and Mengniu at 41.6 billion yuan [2] - Most companies have experienced a decline in revenue and net profit, with China Feihe's revenue down by 9.98% and net profit down by 46.66% [3][4] Group 2 - The overall market is facing pressure, particularly in the ambient liquid milk segment, as consumer preferences shift towards fresh products [5][6] - Price competition is intensifying, with smaller regional companies capturing market share from larger brands [7][8] - Despite revenue declines in liquid milk, some brands like New Dairy have seen growth in high-end product lines, indicating a shift in consumer demand [11] Group 3 - The dairy industry is experiencing a shift towards low-temperature fresh milk, which is gaining popularity over traditional ambient milk [16][20] - Companies are diversifying their product offerings to reduce reliance on liquid milk, with Yili and Mengniu seeing a decrease in the proportion of liquid milk revenue [14][15] - The infant formula segment is becoming increasingly competitive, with Yili and Feihe both claiming the top market share, although their statistics differ [23][24] Group 4 - Government policies, such as child-rearing subsidies, are stimulating demand for infant formula, contributing to revenue growth for several companies [27][28] - High-end infant formula products are gaining traction, with parents willing to spend more on quality, driving market prices upward [30] - Companies are increasingly focusing on B2B markets, with significant growth potential in sectors like food service and coffee [31][32] Group 5 - Major dairy companies are forming strategic partnerships with coffee and tea brands to enhance product sales, indicating a shift towards B2B collaborations [37][40] - The B2B market for dairy products, particularly high-end cream and cheese, is becoming a new growth engine for the industry [40]

Core Viewpoint - The company reported a significant decline in revenue and net profit for 1H25, aligning with previous profit warnings, primarily due to inventory reduction and competitive pressures in the market [1][2]. Revenue Performance - The company's revenue for 1H25 was 9.15 billion yuan, a year-on-year decrease of 9.4%, while the net profit attributable to shareholders was 1 billion yuan, down 46.7% [1]. - The decline in revenue was attributed to intense industry competition, proactive inventory reduction, and delays in new product launches due to regulatory approvals [1]. - The company's market share decreased by over 1 percentage point during the first half of the year, with all product lines experiencing negative growth [1]. Profitability Analysis - The gross profit margin for 1H25 fell by 6.3 percentage points to 61.6%, influenced by impairment losses on bulk powder and a 1.2 billion yuan sales subsidy that negatively impacted revenue [2]. - The sales expense ratio remained stable, while the management expense ratio increased by 1.1 percentage points due to reduced economies of scale from declining revenue [2]. - Additional negative impacts on net profit included a reduction in government subsidies by 150 million yuan and a 100 million yuan increase in fair value losses related to livestock [2]. Future Outlook - The company anticipates continued pressure on revenue in the second half of the year due to ongoing inventory adjustments, although inventory levels have reached historical lows [3]. - A potential improvement in revenue performance is expected starting in September, with a more noticeable recovery in Q4, despite an overall projected double-digit decline for the year [3]. - The company is actively expanding its overseas presence and full lifecycle health business, with current international operations covering North America, the Middle East, and Southeast Asia [3]. Shareholder Returns - The company has announced a minimum dividend of 2 billion yuan for the year, corresponding to a payout ratio of over 90% and a dividend yield of 6.7%, along with a share buyback plan of around 1 billion yuan [3]. Earnings Forecast and Valuation - Due to inventory adjustments and impairment losses, the earnings forecasts for 2025 and 2026 have been reduced by 24% and 17%, respectively, to 2.19 billion yuan and 3.05 billion yuan [3]. - The target price has been lowered by 11.67% to 5.3 HKD, reflecting a price-to-earnings ratio of 20 and 14 times for 2025 and 2026, respectively, with a potential upside of 21% [3].